The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enrollment barriers of adolescents and young adults (AYA) on the non-chemotherapy arm of ARST1321.
 
Lisa M. Kopp
Employment - Covance
 
Damon R. Reed
Consulting or Advisory Role - Epizyme
Travel, Accommodations, Expenses - Salarius Pharmaceuticals
 
Safia K. Ahmed
No Relationships to Disclose
 
Wendy Allen-Rhoades
No Relationships to Disclose
 
Viswatej Avutu
No Relationships to Disclose
 
Yen-Lin Chen
No Relationships to Disclose
 
Lara E. Davis
Consulting or Advisory Role - Epizyme; Epizyme
 
Bree Ruppert Eaton
No Relationships to Disclose
 
Douglas S. Hawkins
Research Funding - Amgen; Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Incyte; Jazz Pharmaceuticals; Lilly (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Seagen
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Celgene; Loxo
 
Daniel J. Indelicato
No Relationships to Disclose
 
Shreyaskumar Patel
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Daiichi Sankyo; Epizyme; Immune Design; Janssen; Lilly; MaxiVax ; Novartis
Research Funding - Blueprint Medicines (Inst)
 
R. Lor Randall
Honoraria - Biomet; Daiichi Sankyo
Travel, Accommodations, Expenses - Biomet; Daiichi Sankyo/Lilly
 
Denise K. Reinke
Research Funding - SARC: Sarcoma Alliance for Research though Collaboration (Inst)
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Ignyta; Lilly; Loxo; NanoCarrier
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Plexxikon (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier
 
Thomas Scharschmidt
Consulting or Advisory Role - Daiichi Sankyo; Stryker
 
Katherine Anne Thornton
Consulting or Advisory Role - Adaptimmune; Agios; Lilly; Macrogenics; More Health
Expert Testimony - Kilcoyne & Nesbitt
 
Dian Wang
No Relationships to Disclose
 
Katherine A. Janeway
Consulting or Advisory Role - Bayer
Patents, Royalties, Other Intellectual Property - Amgen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer
 
Aaron R. Weiss
Travel, Accommodations, Expenses - SpringWorks Therapeutics